Ledger.Open graph →
SEC Form D · filed August 4, 2022

Synthetic Biologics, Inc

Offering
$3.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ROCKVILLE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Jeffrey J. Wolf · Rockville, MDDirectorJeffrey J. Kraws · Rockville, MDDirectorSteven A. Shallcross · Rockville, MDExec · DirectorJohn J. Monahan · Rockville, MDDirectorSimon R. Whiteley · Cheshire, United KingdomDirectorJohn R. Madden · Chapel Hill, NCDirectorEmma R. Bryant · Cheshire, United KingdomExec · DirectorJason Dempsey · Chapel Hill, NCDirectorDmitry Vinogradov · San Francisco, CAExec · DirectorAlexander Nevinskiy · Dover, DEDirectorGrigory Sapunov · San Francisco, CADirectorKonstantin Savenkov · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗